Novo
Novo Nordisk launches obesity drug Wegovy in China
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuanNovo Nordisk said on Monday (Nov 18) it has launched its popular obesity drug...
Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov 6) strong third-quarter earnings despite being held back by...
Rosneft, Lukoil to cut oil exports from Black Sea’s Novo: sources
RUSSIA’S oil producers Rosneft and Lukoil will sharply cut oil exports from the Black Sea port of Novorossiisk in July, two sources familiar with a loading plan said, as...
Ozempic maker Novo plans another US$4.1 billion US factory
Novo Nordisk plans to invest US$4.1 billion in another US factory, ploughing more money into its biggest market amid rising discontent over the cost of its obesity and diabetes...
Novo Nordisk says its Wegovy weight-loss drug wins China approval
Novo Nordisk said on Tuesday (Jun 25) its popular weight-loss drug Wegovy has been approved in China, paving the way for its sales in the world’s second-largest economy.Novo said...
Weight-loss drugmaker Novo Nordisk’s profits soar further
Danish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday (May 2) thanks to the popularity of anti-diabetes and weight-loss drugs Ozempic and Wegovy, which have made it...
Novo Foundation, Nvidia team up to build Danish AI supercomputer
NOVO Nordisk Fonden, the enterprise foundation behind Novo Nordisk, will work with Nvidia to build a supercomputer in Denmark to help research and innovation in health care, life sciences...
US FDA approves Novo Nordisk’s Wegovy for lowering heart risks
THE US Food and Drug Administration approved Novo Nordisk’s weight-loss drug Wegovy on Friday (Mar 8) for lowering the risk of stroke and heart attack in overweight or obese...
- « Previous
- 1
- 2
- 3
- Next »